|
|
ProMetic Announces Changes to Its Board of Directors - EIN News (press release) |
 |
 |
EIN News (press release)
John brings over 25 years of experience in senior executive positions related to clinical affairs, clinical development and marketing in the field of nephrology and end-stage renal diseases. John's appointment is indicative of the importance and
|
|
|
Blood, urine markers can predict heart surgery patients at higher risk for ... - News-Medical.net |
|
|
News-Medical.net
Blood and urine markers can indicate which patients with an abrupt kidney injury following heart surgery will experience progressive kidney problems, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology ...
Weight-Loss Surgery Seems Safe for Kidney Disease Patients Health.com
Weight-loss surgery safe for obese kidney disease patients EurekAlert (press release)
Biomarkers assist in detecting life-threatening kidney injury after cardiac
|
|
A Good Death? No Such Thing - First Things (blog) |
|
|
First Things (blog)
He has reached a point where the toxins of renal failure have begun to occupy his days and his nights. A by-product are deep episodes of hallucination. He sees ants on the floor, stuffed animals coming to life. Most likely, he speculates, these are the
|
|
|
FTC Requires Fresenius to Sell 60 Clinics - Renal Business Today |
|
|
Renal Business Today
WASHINGTON—Fresenius Medical Care AG & Co. has gained a rival dialysis provider, Liberty Dialysis Holdings, Inc., but has been requested by The Federal Trade Commission to sell 60 outpatient dialysis clinics in 43 local markets in order to prevent ...
Liberty Dialysis Completes Fresenius Deal Private Equity Hub (press release)
Liberty Dialysis Holdings, Inc., a Portfolio Company of KRG Capital Partners
|
|
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 ... - Bradenton Herald |
|
|
Bradenton Herald
... a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), ...
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and
|
|
|
|
|
<< Start < Prev 491 492 493 494 495 496 497 498 499 500 Next > End >>
|
|
Page 495 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
